IRadimed Corporation

NASDAQ:IRMD

54.65 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 18.32617.92917.59817.45216.50516.1315.47514.86413.40712.72212.31111.87310.9079.819.2248.5467.6996.7958.67810.8919.9639.2268.4388.3397.6157.3777.1086.7055.695.5245.1635.997.6739.8698.9648.7998.1947.6096.9923.5843.8124.73.5573.4572.482.7752.628
Cost of Revenue 4.1343.9194.214.0393.6673.9443.7543.6432.8652.5822.9312.6232.5022.4782.1622.1071.9581.8652.2142.7422.1681.8582.0481.9821.8271.7111.6921.641.3081.2341.3881.3041.4061.7391.7061.51.591.4221.3280.9190.960.870.6560.9490.670.7680.467
Gross Profit 14.19214.0113.38813.41312.83712.18611.72111.2210.54310.149.389.258.4067.3327.0626.4395.7414.936.4648.1497.7957.3676.396.3575.7885.6665.4175.0654.3824.293.7754.6866.2678.137.2587.2996.6036.1875.6642.6652.8523.8312.9012.5081.812.0072.161
Gross Profit Ratio 0.7740.7810.7610.7690.7780.7550.7570.7550.7860.7970.7620.7790.7710.7470.7660.7530.7460.7260.7450.7480.7820.7990.7570.7620.760.7680.7620.7550.770.7770.7310.7820.8170.8240.810.830.8060.8130.810.7440.7480.8150.8150.7260.730.7230.822
Reseach & Development Expenses 0.6390.8013.8270.650.4530.9620.7940.6050.4920.6630.5190.4950.4810.4540.4760.5130.4770.4830.430.3790.370.3310.3530.3680.3740.3960.380.350.3830.4490.5410.3640.4570.2920.2340.50.5190.4030.3420.3150.3030.2260.2240.3460.2990.2040.16
General & Administrative Expenses 3.9684.1053.9914.2733.6153.4823.9212.6992.8822.4032.7162.5242.2522.5652.432.2072.1975.0022.8632.9682.612.462.4132.1472.1822.0782.3042.1532.5512.192.1071.5781.873.0882.262.1411.6761.9851.9681.3321.2621.131.0930.7210.6410.5280.503
Selling & Marketing Expenses 3.7953.4763.8273.3292.8642.77933.6623.0372.9083.073.1212.5862.472.3793.0692.2822.3742.4342.5622.2972.22.1112.0491.7841.5161.6461.5631.2521.3241.3651.2391.3471.411.2831.3061.2061.1051.0890.7920.8810.8650.760.7190.5140.4960.569
SG&A 7.7637.5814.8127.6036.4796.2626.926.3625.9195.3115.7865.6454.8385.0344.8095.2764.4797.3775.2965.5314.9074.664.5234.1963.9663.5943.9493.7153.8033.5133.4722.8173.2174.4983.5433.4472.8823.093.0572.1242.1431.9951.8521.441.1551.0231.072
Other Expenses 00.6420.495-1.1810.5030.3350.3420.450.1050.013-0.0150.0040.0070.013-0.0060.0140.0090.0180.0990.1150.110.0780.0930.0830.0430.0280.040.0320.0290.0210.030.01-0.004-0.0050.032-0.0360.0650.0460.047-0.055-0.0090.0120.003-0.0420.0190.023-0.003
Operating Expenses 8.4038.3838.6398.2536.9327.2237.7146.9676.415.9736.3056.145.3195.4885.2855.7884.9567.8595.7275.915.2764.9924.8764.5644.343.994.3294.0654.1863.9624.0133.1813.6744.793.7773.9473.4013.4933.3992.4392.4462.2212.0771.7851.4541.2281.232
Operating Income 5.7895.6274.7485.165.9054.9634.0074.2544.1324.1673.0753.113.0871.8441.7770.6510.785-2.9290.7372.2392.5192.3761.5141.7931.4481.6761.08710.1960.328-0.2381.5052.5943.343.4813.3523.2032.6942.2650.2250.4061.610.8240.7230.3560.780.929
Operating Income Ratio 0.3160.3140.270.2960.3580.3080.2590.2860.3080.3280.250.2620.2830.1880.1930.0760.102-0.4310.0850.2060.2530.2580.1790.2150.190.2270.1530.1490.0340.059-0.0460.2510.3380.3380.3880.3810.3910.3540.3240.0630.1070.3430.2320.2090.1430.2810.353
Total Other Income Expenses Net 0.6290.6420.4950.5220.5030.3350.3420.450.1050.013-0.0150.0040.0070.013-0.0060.0140.0090.0180.0990.1150.110.0780.0930.0830.0430.0280.040.0320.0290.0210.030.01-0.004-0.0050.032-0.0360.0650.0460.047-0.055-0.0090.0120.003-0.0420.0190.023-0.003
Income Before Tax 6.4186.2695.2445.6826.4095.2984.354.7044.2374.183.063.1133.0941.8571.7710.6650.794-2.9110.8362.3542.6292.4541.6061.8761.4911.7031.1271.0320.2250.349-0.2091.5152.593.3353.5133.3163.2682.742.3110.1710.3981.6220.8280.6810.3750.8020.925
Income Before Tax Ratio 0.350.350.2980.3260.3880.3280.2810.3160.3160.3290.2490.2620.2840.1890.1920.0780.103-0.4280.0960.2160.2640.2660.190.2250.1960.2310.1590.1540.040.063-0.040.2530.3370.3380.3920.3770.3990.360.3310.0480.1040.3450.2330.1970.1510.2890.352
Income Tax Expense 1.3691.3681.1071.1421.3411.1190.9441.0310.810.9390.573-0.7790.5180.3880.3840.027-0.281-0.799-0.933-0.8880.1740.365-0.2390.169-0.910.3480.2860.8480.032-0.0080.0240.3741.0291.1041.2310.9111.40.9690.824-0.10.160.6030.3040.2070.1140.2440.282
Net Income 5.0494.9014.1374.545.0674.183.4063.6743.4273.2412.4873.8932.5761.471.3870.6371.075-2.1121.7693.2422.4552.0891.8461.7072.41.3550.8410.1840.1920.357-0.2331.1411.562.2312.2822.4051.8671.7711.4870.2710.2371.0190.5230.4740.2610.5580.644
Net Income Ratio 0.2760.2730.2350.260.3070.2590.220.2470.2560.2550.2020.3280.2360.150.150.0750.14-0.3110.2040.2980.2460.2260.2190.2050.3150.1840.1180.0270.0340.065-0.0450.190.2030.2260.2550.2730.2280.2330.2130.0760.0620.2170.1470.1370.1050.2010.245
EPS 0.40.390.330.360.40.330.270.290.270.260.20.310.210.120.110.050.09-0.170.150.280.220.190.170.160.220.130.080.020.020.03-0.0220.110.150.210.210.220.170.160.140.030.020.0980.050.0460.0250.0540.062
EPS Diluted 0.40.380.320.360.40.330.270.290.270.260.20.310.20.120.110.050.09-0.170.140.260.20.170.150.140.20.110.070.020.020.03-0.0220.10.130.190.190.190.150.150.120.020.020.0980.050.0460.0250.0540.062
EBITDA 5.7895.6275.475.8875.9055.154.194.4224.5684.6613.5093.4963.4272.1932.1090.991.116-2.6051.0822.522.8082.6611.9012.0531.4632.0781.5151.3380.3430.328-0.1541.5692.5943.4023.5423.4123.262.7492.3160.2750.4511.6440.8450.7640.3890.8130.961
EBITDA Ratio 0.3160.3250.2830.2960.3580.3190.2710.2860.3410.3660.2850.2940.3140.2230.2290.1160.145-0.3830.1250.2310.2820.2880.2250.2460.1920.2820.2130.20.170.08-0.030.2620.3460.3450.3950.3880.3980.3610.3310.0770.1180.3430.2380.2210.1570.2930.366